Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

The Lancet - Tập 387 Số 10034 - Trang 2218-2225 - 2016
Vinod H. Thourani1, Susheel Kodali2, Raj Makkar3, Howard C. Herrmann4, Mathew Williams5, Vasilis Babaliaros1, Richard W. Smalling6, Scott Lim7, S. Chris Malaisrie8, Samir Kapadia9, Wilson Y. Szeto4, Kevin L. Greason10, Dean J. Kereiakes11, Gorav Ailawadi7, Brian Whisenant12, Chandan Devireddy1, Jonathon Leipsic13, Rebecca T. Hahn2, Philippe Pîbarot14, Neil J. Weissman15, Wael A. Jaber9, David J. Cohen16, Rakesh M. Suri9, E. Murat Tuzcu9, Lars G. Svensson9, John G. Webb13, Jeffrey W. Moses2, Michael J. Mack17, D. Craig Miller18, Craig R. Smith2, Maria Alu2, Rupa Parvataneni19, Ralph B. D’Agostino20, Martin B. Leon2
1Emory University School of Medicine, Atlanta, GA, USA;
2Columbia University Medical Center, New York, NY, USA;
3Cedars-Sinai Medical Center, Los Angeles, CA, USA
4University of Pennsylvania, Philadelphia, PA, USA
5NYU Langone Medical Center, New York, NY, USA
6University of Texas Memorial Hermann Heart and Vascular Institute, Houston, TX, USA
7UNIVERSITY OF VIRGINIA, Charlottesville, VA USA
8Northwestern University, Chicago, IL, USA
9Cleveland Clinic, Cleveland, OH, USA
10Mayo Clinic, Rochester, MN USA
11The Christ Hospital, Cincinnati, OH, USA
12Intermountain Medical Center, Salt Lake City, UT, USA
13St. Paul's Hospital, Vancouver, BC, Canada
14Laval University, Quebec, QC, Canada
15Medstar Health Research Institute and Georgetown University, Washington, DC, USA
16Saint Luke's Mid America Heart Institute, Kansas City, MO, USA
17Baylor Scott and White Healthcare, Plano, TX, USA
18Stanford University, Stanford, CA, USA
19Cardiovascular Research Foundation, New York, NY, USA
20[Wake Forest School of Medicine, Winston-Salem, NC, USA]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, 33, 2451, 10.1093/eurheartj/ehs109

Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, e57, 10.1016/j.jacc.2014.02.536

Mack, 2015, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7

Kapadia, 2015, 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2485, 10.1016/S0140-6736(15)60290-2

Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232

Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510

Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590

Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556

Manoharan, 2015, Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system, JACC Cardiovasc Interv, 8, 1359, 10.1016/j.jcin.2015.05.015

Kodali, 2016, Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk, and intermediate-risk patients with aortic stenosis, Eur Heart J, 10.1093/eurheartj/ehw112

Webb, 2015, A randomized evaluation of the SAPIEN XT transcatheter heart valve system in patients with aortic stenosis who are not candidates for surgery, JACC Cardiovasc Interv, 8, 1797, 10.1016/j.jcin.2015.08.017

Leon MB. Transcatheter Aortic valve replacement compared with surgery in intermediate risk patients with aortic stenosis: final results from the Randomized Placement of Aortic Transcatheter Valves 2 Study. American College of Cardiology (ACC) Scientific Sessions 2016; Chicago, IL, USA; April 2–4.

Pibarot, 2015, Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme, JACC Cardiovasc Imaging, 8, 340, 10.1016/j.jcmg.2015.01.008

Kappetein, 2012, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, J Am Coll Cardiol, 60, 1438, 10.1016/j.jacc.2012.09.001

D'Agostino, 2007, Propensity scores in cardiovascular research, Circulation, 115, 2340, 10.1161/CIRCULATIONAHA.105.594952

D'Agostino, 1998, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B

Holmes, 2015, Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry, J Am Coll Cardiol, 66, 2813, 10.1016/j.jacc.2015.10.021

Wenaweser, 2013, Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation, Eur Heart J, 34, 1894, 10.1093/eurheartj/eht086

Blackstone, 2015, Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy, Circulation, 131, 1989, 10.1161/CIRCULATIONAHA.114.012525

Thourani, 2015, Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients, Ann Thorac Surg, 99, 55, 10.1016/j.athoracsur.2014.06.050

Piazza, 2013, A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients, JACC Cardiovasc Interv, 6, 443, 10.1016/j.jcin.2013.01.136

Latib, 2012, Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study, Am Heart J, 164, 910, 10.1016/j.ahj.2012.09.005

Tamburino, 2015, 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT study, J Am Coll Cardiol, 66, 804, 10.1016/j.jacc.2015.06.013

Holmes, 2015, Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry, J Am Coll Cardiol, 66, 2813, 10.1016/j.jacc.2015.10.021

Moat, 2011, Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry, J Am Coll Cardiol, 58, 2130, 10.1016/j.jacc.2011.08.050

Mohr, 2014, The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease, Eur J Cardiothorac Surg, 46, 808, 10.1093/ejcts/ezu290

Thyregod, 2015, Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial, J Am Coll Cardiol, 65, 2184, 10.1016/j.jacc.2015.03.014

Athappan, 2014, Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature, J Am Coll Cardiol, 63, 2101, 10.1016/j.jacc.2014.02.540

Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384

Kodali, 2014, Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien Valve in the PARTNER trial: characterizing patients and impact on outcomes, Eur Heart J, 36, 449, 10.1093/eurheartj/ehu384